Speaker Profile
                                                                        Biography
                                                                        David W. Craig is an internationally recognized leader in developing and   applying novel bioinformatics and genomics tools as well as in translating   genomic discoveries from bench to bedside. Craig leads an integrative   translational sciences department at City of Hope comprehensive cancer   center that focuses on precision measurement, data science and diversity.   His team seeks to further improve both translational outcomes as well as   the science underpinning the use of precision medicine.Craig collaborates   with regulatory agencies, industry partners, researchers and health care   professionals to integrate scientific findings and translate potentially   practice-changing discoveries into improved patient care and human health.   He has spearheaded collaborative computational and data science efforts   within large and small research consortiums, including the 1000 Genomes   Project and the Bipolar Genome Study. His exceptional expertise has   resulted in more than 200 publications, four patents and two founded   companies.
                                                                    
Talk
AI-Driven Individualized Analysis of Spatial Transcriptomics
Novel methods in spatial transcriptomics methods offer deep insights into   disease biology, advancing the field beyond single-cell genomics to   incorporate the spatial context. Craig describes use of AI, deep learning   and graph-based networks to merge histology and genomic sequencing,   enhancing understanding of tumor biology and guiding analysis for broader   research.
Session Abstract – PMWC 2024 Silicon Valley
                                                                        
                                                                        Track Chair: Stacey Gabriel, Broad Institute and Steve Turner, PacBio
- New Frontiers in Genomic Analysis & Interpretation
- Robert Sebra, ISMMS
- Anshul Kundaje, Stanford
- Chaz Langelier, UCSF
- Orly Alter, Prism AI Inc - From Potential to Reality: Bringing Nanopore Sequencing to Clinical Practice (PANEL)
Chair: Emma Stanton, Oxford Nanopore Tech - Charles Chiu, UCSF
- Billy Tsz Cheong Lau, Stanford - Population Sequencing at Scale: Impact and Future Path of Genomic Programs (PANEL)
Chair: Stacey Gabriel, Broad Institute
- Heidi Rehm, MGH
- Cindy Lawley, Olink
- John M. Gaziano, Million Veterans Program (MVP) - New Frontiers in Genomic Analysis & Interpretation continues: AI in Spatial Transcriptomics in Patient Response
- David. W. Craig, City of Hope Cancer Center
- Premal Shah, MyOme - The Economic Perspective on Genomics (PANEL)
Chair: Bill Hyun, UCSF
- Steve Turner, PacBio
- Alex de Winter, Danaher Ventures
- Kandaswamy (Swamy) Vijayan, Zafrens - Using AI for Scalable Phenotyping and Discovery
- Andrew Carroll, Google
 - Building Bridges: Precision Medicine Communities
- Kumar Prashant, Karkinos - NCI Showcase
- Xiaofeng Xie, MicrOmics Technologies 




